|
CO5180550A1
(es)
|
1999-04-19 |
2002-07-30 |
Smithkline Beecham Corp |
Inhibidores de fab i
|
|
CO5370679A1
(es)
|
1999-06-01 |
2004-02-27 |
Smithkline Beecham Corp |
Inhibidores fab 1
|
|
US6762201B1
(en)
|
1999-10-08 |
2004-07-13 |
Affinium Pharmaceuticals, Inc. |
Fab I inhibitors
|
|
ATE285821T1
(de)
|
1999-10-08 |
2005-01-15 |
Affinium Pharm Inc |
Fab i inhibitoren
|
|
US6730684B1
(en)
|
1999-10-08 |
2004-05-04 |
Affinium Pharmaceuticals, Inc. |
Fab I inhibitors
|
|
CA2444597A1
(en)
*
|
2001-04-06 |
2002-10-06 |
Affinium Pharmaceuticals, Inc. |
Fab i inhibitors
|
|
EP1575951B1
(en)
*
|
2002-12-06 |
2014-06-25 |
Debiopharm International SA |
Heterocyclic compounds, methods of making them and their use in therapy
|
|
DE602004016831D1
(de)
|
2003-03-17 |
2008-11-13 |
Affinium Pharm Inc |
Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
|
|
EP2848614A3
(en)
*
|
2004-06-04 |
2015-07-29 |
Debiopharm International SA |
Acrylamide derivatives as antibiotic agents
|
|
EP1973902A2
(en)
*
|
2005-12-05 |
2008-10-01 |
Affinium Pharmaceuticals, Inc. |
3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
|
|
EP1990335A4
(en)
|
2006-03-02 |
2009-11-11 |
Astellas Pharma Inc |
17-BETA-HSD-type-5 INHIBITOR
|
|
EP2687533B1
(en)
*
|
2006-07-20 |
2017-07-19 |
Debiopharm International SA |
Acrylamide derivatives as FAB I inhibitors
|
|
WO2008098374A1
(en)
|
2007-02-16 |
2008-08-21 |
Affinium Pharmaceuticals, Inc. |
Salts, prodrugs and polymorphs of fab i inhibitors
|
|
JP2013542960A
(ja)
*
|
2010-11-08 |
2013-11-28 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ナンバー２、リミテッド |
脂肪酸シンターゼ阻害剤
|
|
SI2861608T1
(sl)
|
2012-06-19 |
2019-08-30 |
Debiopharm International Sa |
Derivati predzdravila (E)-N-metil-N-((3-metilbenzofuran-2-IL)metil)- 3-(7-okso-5,6,7,8-tetrahidro-1 ,8-nafthiridin-3-il)akrilamid
|
|
SG10201707409PA
(en)
|
2013-03-13 |
2017-10-30 |
Forma Therapeutics Inc |
Novel compounds and compositions for inhibition of fasn
|
|
BR122023021456A2
(pt)
|
2016-02-26 |
2024-02-20 |
Debiopharm International S.A. |
Uso de di-hidrogeno fosfato de {6- [(e)-3-{metil[(3-metil-1-benfofuran-2- iol)metil]amino)-3- oxopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)- il}metila para tratamento de osteomielite do pé diabético e composição farmacêutica
|
|
US11690824B2
(en)
|
2018-04-10 |
2023-07-04 |
The General Hospital Corporation |
Antibacterial compounds
|
|
TWI767148B
(zh)
|
2018-10-10 |
2022-06-11 |
美商弗瑪治療公司 |
抑制脂肪酸合成酶(fasn)
|
|
US10793554B2
(en)
|
2018-10-29 |
2020-10-06 |
Forma Therapeutics, Inc. |
Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone
|
|
LT3923914T
(lt)
|
2019-02-14 |
2023-07-25 |
Debiopharm International S.A. |
Afabicino kompozicija, jos gamybos būdas
|
|
CN113939306B
(zh)
|
2019-06-14 |
2024-07-19 |
德彪药业国际股份公司 |
用于治疗涉及生物膜的细菌感染的药物及其用途
|